TANDEM DIABETES CARE INC
TNDMUS売上高
$1.0B
百万USD
営業利益
$-187M
百万USD
純利益
$-205M
百万USD
ROE
-131.9%
最新FY
EPS
$-3.04
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $141M | $-5M | - |
| FY2021 | Q2 | $172M | $4M | $0.06 |
| FY2021 | Q3 | $180M | $6M | $0.09 |
| FY2021 | FY | $703M | $16M | $0.24 |
| FY2022 | Q1 | $176M | $-15M | $-0.23 |
| FY2022 | Q2 | $200M | $-15M | $-0.24 |
| FY2022 | Q3 | $205M | $-49M | $-0.76 |
| FY2022 | FY | $801M | $-95M | $-1.47 |
| FY2023 | Q1 | $169M | $-124M | $-1.92 |
| FY2023 | Q2 | $196M | $-36M | $-0.55 |
| FY2023 | Q3 | $186M | $-33M | $-0.51 |
| FY2023 | FY | $748M | $-223M | $-3.43 |
| FY2024 | Q1 | $192M | $-43M | $-0.65 |
| FY2024 | Q2 | $222M | $-31M | $-0.47 |
| FY2024 | Q3 | $244M | $-23M | $-0.35 |
| FY2024 | FY | $940M | $-96M | $-1.47 |
| FY2025 | Q1 | $234M | $-131M | $-1.97 |
| FY2025 | Q2 | $241M | $-52M | $-0.78 |
| FY2025 | Q3 | $249M | $-21M | $-0.31 |
| FY2025 | FY | $1.0B | $-205M | $-3.04 |
| FY2026 | Q1 | $247M | $-20M | $-0.30 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $184M | $362M | $499M | $703M | $801M | $748M | $940M | $1.0B |
| 営業利益 | $-78M | $-63M | $-45M | $-17M | $-8M | $23M | $-93M | $-233M | $-99M | $-187M |
| 純利益 | $-83M | $-73M | $-123M | $-25M | $-34M | $16M | $-95M | $-223M | $-96M | $-205M |
| 総資産 | $112M | $95M | $206M | $326M | $716M | $905M | $1.1B | $953M | $968M | $881M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $-6M | $-29M | $131M | $195M | $366M | $433M | $440M | $314M | $263M | $155M |
| 営業CF | - | - | $-8M | $42M | $25M | $111M | $50M | $-32M | $24M | $-10M |
| EPS | - | - | - | - | - | $0.24 | $-1.47 | $-3.43 | $-1.47 | $-3.04 |
| BPS | $-0.19 | $-0.65 | $2.27 | $3.26 | $5.86 | $6.78 | $6.82 | $4.78 | $3.96 | $2.27 |
| ROE | 1407.9% | 250.6% | -93.4% | -12.7% | -9.4% | 3.6% | -21.5% | -71.0% | -36.5% | -131.9% |